NTLA EBITDA
Intellia Therapeutics Inc · EBITDA
NTLA EBITDA
Latest reported-$390.38Mperiod ending
NTLA EBITDA (-$9.54M → -$390.38M)
Annual EBITDA
High-resolution chart · PNG
NTLA ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -396,771,000 | |
| -508,736,000 | |
| -472,216,000 | |
| -466,614,000 | |
| -261,001,000 | |
| -130,272,000 | |
| -100,781,000 | |
| -86,406,000 | |
| -66,561,000 | |
| -31,055,000 | |
| -13,081,000 | |
| -9,536,000 |